This page shows the latest Concordia news and features for those working in and with pharma, biotech and healthcare.
Concordia accused of overcharging NHS for thyroid drug. The pharma firm said to have ‘abused’its position within the UK market. ... Markets Authority (CMA), which says Concordia “abused its dominant position to overcharge the NHS”.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn ... level. AMCo's commercial footprint reaches across 100
J&J divest subsidiary marketing vascular devices. 1, 944. Covis / Concordia.
Covis (asset). Concordia. 1.2. 8.2. NR. Hyperion. Horizon. 1.1. 9.6. 35%.
341. Revive Pharmaceuticals/ Concordia Healthcare. Product acquisition. Donnatal, adjunctive therapy for IBS and acute enterocolitis (marketed).
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...